Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 3/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | CHRM2 | P08172 | 7/20 | 0.44 |
| ▸ | CHRM4 | P08173 | 7/20 | 0.44 |
| ▸ | CHRM5 | P08912 | 7/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 7/20 | 0.44 |
| ▸ | CHRM3 | P20309 | 7/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5889310 | 0.88 | SLC6A3 (0.40) | L3MBTL1KDM4EMAPK1CHRM2CHRM4 | |
| SCHEMBL5889311 | 0.81 | HRH2 (0.42) | L3MBTL1 | |
| SCHEMBL1902454 | 0.75 | MEN1 (0.43) | KDM4EHPGDTSHRMEN1KMT2A | |
| SCHEMBL8178869 | 0.74 | RAB9A (0.48) | L3MBTL1KDM4ETSHRMEN1KMT2A | |
| SCHEMBL9721781 | 0.73 | CHRM2 (0.59) | PPARGL3MBTL1KDM4EMAPK1CHRM2 | |
| SCHEMBL1196367 | 0.70 | PPARG (0.59) | PPARGL3MBTL1KDM4EMAPK1CHRM2 | |
| SCHEMBL18674041 | 0.69 | PPARG (0.65) | PPARGMAPK1CHRM2CHRM4CHRM5 | |
| SCHEMBL13082527 | 0.69 | CHRM2 (0.55) | PPARGL3MBTL1KDM4EMAPK1CHRM2 | |
| SCHEMBL9092954 | 0.69 | TSHR (0.72) | PPARGL3MBTL1KDM4EMAPK1CHRM2 | |
| SCHEMBL8733030 | 0.68 | PPARG (0.60) | PPARGL3MBTL1KDM4EMAPK1CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7122506-B2 | Cyclic imines as pesticides | BAYER AKTIENGESELLSCHAFT (DE) | 2006-10-17 | — | — | US | disclosed |
| EP-1077938-B1 | 2-(2-METHYLPHENYL)-3,4-DIHYDRO-2H-PYRROL DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2005-04-13 | — | — | EP | disclosed |
| US-20040186287-A1 | Cyclic imines as pesticides | PLANT ANDREW (DE) | 2004-09-23 | — | — | US | disclosed |
| EP-1080072-B1 | 2-(2-CHLOROPHENYL)-3,4-DIHYDRO-2H-PYRROL DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2004-08-04 | — | — | EP | disclosed |
| US-6770595-B2 | ACTIVITY AGAINST ARTHROPODS IN AGRICULTURE AND PARASITES ENCOUNTERED IN ANIMAL HUSBANDRY | BAYER AKTIENGESELLSCHAFT (DE) | 2004-08-03 | — | — | US | disclosed |
| US-6599924-B1 | 2-hetaryl-3,4 dihydro-2H-pyrrole pesticide | BAYER AKTIENGESELLSCHAFT (DE) | 2003-07-29 | — | — | US | disclosed |
| EP-1306371-A1 | Cyclic imines | Bayer CropScience AG (DE) | 2003-05-02 | — | — | EP | disclosed |
| EP-0942901-B1 | CYCLIC IMINES AS PESTICIDES | BAYER CROPSCIENCE AG (DE) | 2003-03-05 | — | — | EP | disclosed |
| US-20020151571-A1 | Cyclic imines as pesticides | PLANT ANDREW (DE) | 2002-10-17 | — | — | US | disclosed |
| US-6399771-B1 | AGRICULTURE; VETERINARY MEDICINE | BAYER AKTIENGESELLSCHAFT (DE) | 2002-06-04 | — | — | US | disclosed |
| US-6274613-B1 | APPLYING COMPOUNDS SUCH AS A GAMMA-ETHOXY-GAMMA-BUTYROLACTAM TO PESTS AND/OR THEIR HABITATS | BAYER AKTIENGESELLSCHAFT (DE) | 2001-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020151571-A1 | Cyclic imines as pesticides | DDT, CYP1A1, AR | PPARG 1650/4885L3MBTL1 1894/4885KDM4E 3187/4885 |
| US-20040186287-A1 | Cyclic imines as pesticides | DDT, CYP1A1, AR | PPARG 1682/4885L3MBTL1 1810/4885KDM4E 3150/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.